Activating Compound | Comment | Organism | Structure |
---|---|---|---|
glutathione | - |
Homo sapiens |
Cloned (Comment) | Organism |
---|---|
gene DAGLA, DNA and amino acid sequence determination and analysis, sequence comparisons of the two isozymes, real-time RT-PCR analysis of DAGLalpha expression, recombinant expression of V5- and His-tagged isozyme DAGLalpha in COS-7 cells | Homo sapiens |
gene DAGLB, DNA and amino acid sequence determination and analysis, sequence comparisons of the two isozymes, recombinant expression of FLAG-tagged isozyme DAGLbeta in COS-7 cells | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
HgCl2 | - |
Homo sapiens | |
additional information | no inhibition by PMSF; no inhibition by PMSF | Homo sapiens | |
p-hydroxy-mercuri-benzoate | - |
Homo sapiens | |
RHC80267 | blocks 2-AG formation from intact cells; blocks 2-AG formation from intact cells | Homo sapiens | |
tetrahydrolipstatin | THL, THL inhibits the neurite outgrowth response stimulated by FGF2, at 100 nM it inhibits 66.7%, 93.5% and 99.2% of AG-2 release in N18-TG2, C6, and RBL-2H3 cells, respectively. IC50 of 0.002 mM for the inhibition by THL of FGF2 response; THL, THL inhibits the neurite outgrowth response stimulated by FGF2, at 100 nM it inhibits 66.7%, 93.5% and 99.2% of AG-2 release in N18-TG2, C6, and RBL-2H3 cells, respectively. IC50 of 0.002 mM for the inhibition by THL of FGF2 response | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.1588 | - |
sn-1-stearoyl-2-arachidonoyl-glycerol | pH 7.0, 37°C | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | - |
Homo sapiens | 16020 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Ca2+ | required for activity | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
1,2-di-(9Z-octadecenoyl)-sn-glycerol + H2O | Homo sapiens | the reaction proceeds in the forward direction | (9Z)-octadecenoate + 2-(9Z-octadecenoyl)-glycerol | - |
? | |
1-(9Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol + H2O | Homo sapiens | the reaction proceeds in the forward direction | (9Z)-octadecenoate + 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol | - |
? | |
1-(9Z-octadecenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycerol + H2O | Homo sapiens | the reaction proceeds in the forward direction | (9Z)-octadecenoate + 2-(9Z,12Z-octadecadienoyl)-glycerol | - |
? | |
1-(9Z-octadecenoyl)-2-O-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol + H2O | Homo sapiens | the reaction proceeds in the forward direction | (9Z)-octadecenoate + 2-O-(5Z,8Z,11Z,14Z)-eicosatetraenoylglycerol | - |
? | |
1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycerol + H2O | Homo sapiens | the reaction proceeds in the forward direction | (9Z)-octadecenoate + 2-octadecanoylglycerol | - |
? | |
1-acyl-2-arachidonoyl-sn-glycerol + H2O | Homo sapiens | - |
2-arachidonoylglycerol + fatty acid | - |
? | |
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol + H2O | Homo sapiens | the reaction proceeds in the forward direction | 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + octadecanoate | - |
? | |
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol + H2O | Homo sapiens | the reaction proceeds in the forward reaction | 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + octadecanoate | - |
? | |
sn-1-stearoyl-2-arachidonoyl-glycerol + H2O | Homo sapiens | - |
2-arachidonoylglycerol + stearate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q8NCG7 | - |
- |
Homo sapiens | Q9Y4D2 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | two closely related genes are identified and their expression in cells correlates with 2-arachidonoylglycerol (2-AG) biosynthesis and release. The expression of both enzymes changes from axonal tracts in the embryo to dendritic fields in the adult, and this correlates with the developmental change in requirement for 2-AG synthesis from the pre- to the postsynaptic compartment. This switch provides a possible explanation for a fundamental change in endocannabinoid function during brain development | Homo sapiens | - |
C6 glioma cell | - |
Homo sapiens | - |
Caco-2 cell | - |
Homo sapiens | - |
embryo | - |
Homo sapiens | - |
HEK-293 cell | - |
Homo sapiens | - |
additional information | real-time RT-PCR analysis of DAGLalpha expression in various tissues | Homo sapiens | - |
N18TG2 cell | neuroblastoma cells | Homo sapiens | - |
neuron | - |
Homo sapiens | - |
RBL-2H3 cell | basophilic leukemia cells | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
1,2-di-(9Z-octadecenoyl)-sn-glycerol + H2O | the reaction proceeds in the forward direction | Homo sapiens | (9Z)-octadecenoate + 2-(9Z-octadecenoyl)-glycerol | - |
? | |
1-(9Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol + H2O | the reaction proceeds in the forward direction | Homo sapiens | (9Z)-octadecenoate + 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol | - |
? | |
1-(9Z-octadecenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycerol + H2O | the reaction proceeds in the forward direction | Homo sapiens | (9Z)-octadecenoate + 2-(9Z,12Z-octadecadienoyl)-glycerol | - |
? | |
1-(9Z-octadecenoyl)-2-O-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol + H2O | the reaction proceeds in the forward direction | Homo sapiens | (9Z)-octadecenoate + 2-O-(5Z,8Z,11Z,14Z)-eicosatetraenoylglycerol | - |
? | |
1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycerol + H2O | the reaction proceeds in the forward direction | Homo sapiens | (9Z)-octadecenoate + 2-octadecanoylglycerol | - |
? | |
1-acyl-2-arachidonoyl-sn-glycerol + H2O | - |
Homo sapiens | 2-arachidonoylglycerol + fatty acid | - |
? | |
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol + H2O | the reaction proceeds in the forward direction | Homo sapiens | 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + octadecanoate | - |
? | |
1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol + H2O | the reaction proceeds in the forward reaction | Homo sapiens | 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + octadecanoate | - |
? | |
sn-1-stearoyl-2-arachidonoyl-glycerol + H2O | - |
Homo sapiens | 2-arachidonoylglycerol + stearate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
DAGLA | - |
Homo sapiens |
DAGLalpha | - |
Homo sapiens |
DAGLB | - |
Homo sapiens |
DAGLbeta | - |
Homo sapiens |
neural stem cell-derived dendrite regulator | UniProt | Homo sapiens |
sn1-DAG lipase | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7 | - |
- |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | enzyme sn1-DAG lipase is involved in the spatial and temporal regulation of endocannabinoid signaling in the brain. The diacylglycerol (DAG) lipase activity is required for axonal growth during development and for retrograde synaptic signaling at mature synapses. This enzyme synthesizes the endocannabinoid 2-arachidonoyl-glycerol (2-AG), and the CB1 cannabinoid receptor is also required for the above responses | Homo sapiens |